CTXR
Price
$1.77
Change
-$0.16 (-8.29%)
Updated
Jul 9 closing price
Capitalization
19.78M
VERA
Price
$24.21
Change
+$1.21 (+5.26%)
Updated
Jul 9 closing price
Capitalization
1.54B
28 days until earnings call
Interact to see
Advertisement

CTXR vs VERA

Header iconCTXR vs VERA Comparison
Open Charts CTXR vs VERABanner chart's image
Citius Pharmaceuticals
Price$1.77
Change-$0.16 (-8.29%)
Volume$1.53M
Capitalization19.78M
Vera Therapeutics
Price$24.21
Change+$1.21 (+5.26%)
Volume$1.01M
Capitalization1.54B
CTXR vs VERA Comparison Chart in %
Loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTXR vs. VERA commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Buy and VERA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (CTXR: $1.77 vs. VERA: $24.21)
Brand notoriety: CTXR and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 45% vs. VERA: 49%
Market capitalization -- CTXR: $19.78M vs. VERA: $1.54B
CTXR [@Biotechnology] is valued at $19.78M. VERA’s [@Biotechnology] market capitalization is $1.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, CTXR is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 5 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • CTXR’s TA Score: 5 bullish, 4 bearish.
  • VERA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VERA is a better buy in the short-term than CTXR.

Price Growth

CTXR (@Biotechnology) experienced а -15.71% price change this week, while VERA (@Biotechnology) price change was +2.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.58%. For the same industry, the average monthly price growth was +16.60%, and the average quarterly price growth was +18.46%.

Reported Earning Dates

CTXR is expected to report earnings on May 14, 2025.

VERA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+12.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.54B) has a higher market cap than CTXR($19.8M). VERA YTD gains are higher at: -42.752 vs. CTXR (-55.750). CTXR has higher annual earnings (EBITDA): -42.77M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. CTXR (26.4K). CTXR has less debt than VERA: CTXR (932K) vs VERA (54.5M). CTXR (0) and VERA (0) have equivalent revenues.
CTXRVERACTXR / VERA
Capitalization19.8M1.54B1%
EBITDA-42.77M-167.77M25%
Gain YTD-55.750-42.752130%
P/E RatioN/AN/A-
Revenue00-
Total Cash26.4K590M0%
Total Debt932K54.5M2%
FUNDAMENTALS RATINGS
CTXR: Fundamental Ratings
CTXR
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTXRVERA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 13 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NIEAX18.51N/A
N/A
BNY Mellon International Equity A
DCGVX41.52N/A
N/A
BNY Mellon Dynamic Value Fund C
PMJAX10.50N/A
N/A
PIMCO RAE US Small A
PGWTX37.73N/A
N/A
Putnam Focused Equity R6
LYFIX12.22N/A
N/A
AlphaCentric Life Sciences & Hlthcare I

CTXR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with HYPD. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
-8.53%
HYPD - CTXR
37%
Loosely correlated
-6.66%
KLTO - CTXR
32%
Poorly correlated
+2.24%
ALEC - CTXR
31%
Poorly correlated
+8.55%
VERA - CTXR
28%
Poorly correlated
+5.26%
TAOX - CTXR
28%
Poorly correlated
-13.17%
More